Natalia Scaramellini

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Sickle Cell Disease

Iron Deficiency

Clinical Practice

Top Venues

American journal of hematology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Daniele Lello Panzieri, Dario Consonni, Natalia Scaramellini, Guido Ausenda, Francesca Granata, Nancy Caponio, Lorena Duca, Simona Leoni, Silvia Elli, Marta Ferraresi, Vittorio Bolis, Cristina Curcio, Milena Agata Irrera, Diletta Maira, Giovanna Graziadei, Elena Cassinerio, Maria Domenica Cappellini, Rayan Bou-Fakhredin, Valentina Brancaleoni, Irene Motta
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion-dependent β-thalassemia. American journal of hematology (2024)
Natalia Scaramellini, Dania Fischer, Anand R Agarvas, Irene Motta, Martina U Muckenthaler, Christina Mertens
Interpreting Iron Homeostasis in Congenital and Acquired Disorders. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Natalia Scaramellini, Dania Fischer, Anand R Agarvas, Irene Motta, Martina U Muckenthaler, Christina Mertens
Interpreting Iron Homeostasis in Congenital and Acquired Disorders. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Natalia Scaramellini, Dania Fischer, Anand R Agarvas, Irene Motta, Martina U Muckenthaler, Christina Mertens
Interpreting Iron Homeostasis in Congenital and Acquired Disorders. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Natalia Scaramellini, Giorgio Croci, Claudio De Magistris, Daniele Lello Panzieri, Elena Cassinerio, Alessia Marcon, Fabio Nascimbeni, Antonella Quarta, Maria Domenica Cappellini, Irene Motta
Splenomegaly: Dare to think rare. American journal of hematology 97 (9) (2022)
Natalia Scaramellini, Dario Consonni, Elena Cassinerio, Carola Arighi, Alessia Marcon, Giovanna Graziadei, Maria Domenica Cappellini, Irene Motta
A holistic approach to iron chelation therapy in transfusion-dependent thalassemia patients with serum ferritin below 500 μg/L. American journal of hematology 95 (9) (2020)